AbbVie to Showcase Breadth of Oncology Portfolio and Pipeline at the 2021 ASCO and EHA Annual Congresses
ABBVie will present results from 43 abstracts across 12 types of cancer during the upcoming virtual American Society of Clinical Oncology Annual Meeting and the virtual European Hematology Association congress . “We are advancing discovery and innovation to improve on the standards of care for blood cancer treatment,” said Mohamed Zaki M.D., Ph.D., vice president and global head of oncology development, AbbVie. “We …
– ABBVie (NYSE: ABBV) will present results from 43 abstracts across 12 types of cancer during the upcoming virtual American Society of Clinical Oncology (ASCO) Annual Meeting ( June 4-8 ) and the virtual European Hematology Association (EHA) congress ( June 9-17 ).
Message :
Required fields Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45
National Task Force supports Cologuard
® as a screening option and screening expands to an additional
˜19 million Americans
MADISON, Wis.-
May 18, 2021 - The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendationthat screening begin at age 45. Exact Sciences (NASDAQ: EXAS) Cologuard
®, referred to as sDNA-FIT, is included as a recommended screening option for all average-risk patients between the ages of 45 and 75. Colorectal cancer is the second leading cause of cancer death in the United States, in part because many cancers go undetected until later stages when treatment options are limited.
Most people with cancer or undergoing active treatment for the disease should get vaccinated against COVID-19 at the earliest opportunity, experts say but it’s still not known how well protected they are from the virus after getting inoculated.
Medically Reviewed
At the beginning of the pandemic, skipping routine screenings seemed like a good idea. Now experts say there may be dire consequences.
Yuliya Baranych/iStock
Last March, when the COVID-19 outbreak was declared a pandemic, many medical facilities shuttered themselves to everyone but those suffering from the virus or in need of necessary medical care.
The thinking: Spare medical facilities for the unfolding emergency and avoid exposing people seeking nonemergency medical care to the virus. Preventive care could wait.
But as the pandemic raged on, concern grew among cancer experts around one issue in particular: screening.
Cancer screening provides one of the best ways to find cancer early, at a time when it s most treatable. With few exceptions, multiple cancer screening tests are recommended for early cancer detection across any adult’s lifetime.
Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.